Rogletimide

From WikiMD.org
Jump to navigation Jump to search

Rogletimide

Rogletimide (pronunciation: roh-gleh-tih-mide) is a type of drug that belongs to the class of medication known as anti-estrogens. It was primarily used in the treatment of breast cancer.

Etymology

The term "Rogletimide" is derived from the chemical name of the drug, which is 3-(4-(2-(1,2,4-triazol-1-ylmethyl)benzoyl)phenoxy)-N,N-dimethylpropan-1-amine. The name is a combination of parts of the chemical structure, with "rog" referring to the benzoyl group, "let" referring to the phenoxy group, and "imide" referring to the triazolylmethyl group.

Usage

Rogletimide was used as a second-line treatment for postmenopausal women with advanced breast cancer. It works by blocking the effects of estrogen in the body, which can slow or stop the growth of certain types of breast cancer cells that need estrogen to grow.

Related Terms

  • Anti-estrogen: A type of drug that blocks the effects of estrogen in the body.
  • Breast cancer: A type of cancer that forms in the cells of the breasts.
  • Postmenopausal: Referring to the time after a woman's menstrual periods have stopped permanently.
  • Advanced breast cancer: A stage of breast cancer where the disease has spread beyond the breast to other parts of the body.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski